To determine whether ROMO1 was differentially expressed among pathological stages, we first analyzed the correlations between mRNA expression of ROMO1 and pathological stages among gastrointestinal tumors using GEPIA2. This evidence concerns the gene ROMO1 and digestive system neoplasm.